A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia

Completed · Phase 2 · Has a placebo group

Conditions studied: Nocturia, Prostatic Hyperplasia

In brief

Silodosin is compared to placebo to determine if it is safe and effective for the treatment of nighttime urination (nocturia) in men with BPH

Key facts

Study ID

NCT00793819

Run by

Watson Pharmaceuticals

People needed

215

Starts

2009-01-01

Expected to finish

2009-10-01

Last updated by the study team

2012-03-09

Who can join

Age: 50 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Males in good general health and at least 50 years of age, with symptoms of moderate to severe BPH and nocturia (>=2 episodes per night)

You may not qualify if…

• Medical conditions that would confound the efficacy evaluation.
• Medical conditions in which it would be unsafe to use an alpha-blocker.
• The use of concomitant drugs that would confound the efficacy evaluation.
• The use of concomitant drugs that would be unsafe with this alpha-blocker.

Where it is running

• Watson Investigational Site — Huntsville, Alabama, United States
• Watson Investigational Site — Laguna Hills, California, United States
• Watson Investigational Site — San Diego, California, United States
• Watson Investigational Site — Aventura, Florida, United States
• Watson Investigational Site — Clearwater, Florida, United States
• Watson Investigational Site — Orlando, Florida, United States
• Watson Investigational Site — Marietta, Georgia, United States
• Watson Investigational Site — Sandy Springs, Georgia, United States
• Watson Investigational Site — Coeur d'Alene, Idaho, United States
• Watson Investigational Site — West Des Moines, Iowa, United States
• Watson Investigational Site — Paducah, Kentucky, United States
• Watson Investigational Site — Greenbelt, Maryland, United States
• Watson Investigational Site — Troy, Michigan, United States
• Watson Investigational Site — Missoula, Montana, United States
• Watson Investigational Site — Omaha, Nebraska, United States
• Watson Investigational Site — Las Vegas, Nevada, United States
• Watson Investigational Site — Lawrenceville, New Jersey, United States
• Watson Investigational Site — Albuquerque, New Mexico, United States
• Watson Investigational Site — Bay Shore, New York, United States
• Watson Investigational Site — New York, New York, United States
• Watson Investigational Site — Williamsville, New York, United States
• Watson Investigational Site — Concord, North Carolina, United States
• Watson Investigational Site — Salisbury, North Carolina, United States
• Watson Investigational Site — Bethany, Oklahoma, United States
• Watson Investigational Site — Bala-Cynwyd, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.